This topic contains a solution. Click here to go to the answer

Author Question: The level of detail and the amount of area covered on a map depends on the ________, which is the ... (Read 69 times)

joe

  • Hero Member
  • *****
  • Posts: 627
The level of detail and the amount of area covered on a map depends on the ________, which is the relationship of a feature's size on a map to its actual size on Earth.
 
  A) map shape
  B) map scale
  C) map projection
  D) map legend
  E) none of the above

Question 2

In map projections, which of the following is NOT one of the possible distortions that can result?
 
  A) location
  B) shape
  C) distance
  D) relative size
  E) direction



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

frejo

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

Answer: B

Answer to Question 2

Answer: A




joe

  • Member
  • Posts: 627
Reply 2 on: Jul 14, 2018
Excellent


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library